Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Clinical trial NCT05401357 · RECRUITING

Trial details

NCT number: NCT05401357
Sponsor: Amneal Pharmaceuticals, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma, Open-Angle Ocular Hypertension

Start date: 2022-06-29
Primary completion: 2022-12-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.